Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Medulloblastoma 2Central Nervous System Neoplasms 2Sarcoma 1Recurrence 1Pleuropulmonary blastoma 1Neuroblastoma 1Lymphoma 1Liver Neoplasms 1Kidney Neoplasms 1Hodgkin Disease 1Hepatoblastoma 1Familial ependymoma 1Astrocytoma 1

Interventions

Filgrastim 13Temozolomide 9Carboplatin 7Peripheral Blood Stem Cell Transplantation 6Cyclophosphamide 5sargramostim 4Magnetic Resonance Spectroscopy 4Irinotecan 4Etoposide 4Topotecan 3Thiotepa 3Radiotherapy 3Oxaliplatin 3O(6)-benzylguanine 3Granulocyte Colony-Stimulating Factor 3Busulfan 3etoposide phosphate 2Vorinostat 2Vincristine 2Specimen Handling 2Psychiatric Rehabilitation 2Melphalan 2Ifosfamide 2Erlotinib Hydrochloride 2Cyproheptadine 2Cisplatin 2Carmustine 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2veliparib 1trioctyl phosphine oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Familial ependymoma × Gene Rearrangement × CNS × Clear all
NCT00006342 2015-10-15

Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor

Duke University

Completed
19 enrolled
CNSLymphoid

Familial ependymoma, Astrocytoma, Hodgkin Disease, Lymphoma, Medulloblastoma, Recurrence, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡